145 related articles for article (PubMed ID: 32505664)
21. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
22. Systematic and experimental investigations of the anti-colorectal cancer mediated by genistein.
Zhang L; Zhang J; Gong Y; Lv L
Biofactors; 2020 Nov; 46(6):974-982. PubMed ID: 32951326
[TBL] [Abstract][Full Text] [Related]
23. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.
Lu M; Wang C; Wang J
Int J Oncol; 2016 Aug; 49(2):603-10. PubMed ID: 27279458
[TBL] [Abstract][Full Text] [Related]
25. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
26. UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.
Signore M; Buccarelli M; Pilozzi E; De Luca G; Cappellari M; Fanciulli M; Goeman F; Melucci E; Biffoni M; Ricci-Vitiani L
Oncotarget; 2016 Jul; 7(28):44113-44128. PubMed ID: 27286453
[TBL] [Abstract][Full Text] [Related]
27. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
[TBL] [Abstract][Full Text] [Related]
28. LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
Yang Z; An Y; Wang N; Dong X; Kang H
J Cell Physiol; 2020 Oct; 235(10):7449-7464. PubMed ID: 32064615
[TBL] [Abstract][Full Text] [Related]
29. Long non‑coding RNA CASC2 enhances berberine‑induced cytotoxicity in colorectal cancer cells by silencing BCL2.
Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
Mol Med Rep; 2019 Aug; 20(2):995-1006. PubMed ID: 31173223
[TBL] [Abstract][Full Text] [Related]
30. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
[TBL] [Abstract][Full Text] [Related]
31. Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells.
Rawat L; Hegde H; Hoti SL; Nayak V
Biomed Pharmacother; 2020 Aug; 128():110243. PubMed ID: 32470748
[TBL] [Abstract][Full Text] [Related]
32. Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators.
Zhang XQ; Yang CY; Rao XF; Xiong JP
Eur J Gynaecol Oncol; 2016; 37(1):30-5. PubMed ID: 27048106
[TBL] [Abstract][Full Text] [Related]
33. Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.
Raghu D; Karunagaran D
J Nat Prod; 2014 May; 77(5):1130-4. PubMed ID: 24828199
[TBL] [Abstract][Full Text] [Related]
34. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
[TBL] [Abstract][Full Text] [Related]
35. Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells.
Wang T; Wu F; Jin Z; Zhai Z; Wang Y; Tu B; Yan W; Tang T
Food Chem Toxicol; 2014 Feb; 64():177-83. PubMed ID: 24296134
[TBL] [Abstract][Full Text] [Related]
36. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
[TBL] [Abstract][Full Text] [Related]
37. Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
Yang W; Shi J; Zhou Y; Liu T; Zhan F; Zhang K; Liu N
Int J Oncol; 2019 Aug; 55(2):439-450. PubMed ID: 31268166
[TBL] [Abstract][Full Text] [Related]
38. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Sulik M; Kmiec Z
Oncol Rep; 2017 Jul; 38(1):201-210. PubMed ID: 28586030
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
[TBL] [Abstract][Full Text] [Related]
40. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.
Sun LC; Qian HX
Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
